Spots Global Cancer Trial Database for Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma
Official Title: Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma: Observational Study
Study ID: NCT04416646
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of Cabozantinib in the treatment of patients with renal cell carcinoma.
Detailed Description:
Keywords
Eligibility
Minimum Age: 70 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Istituto Oncologico Veneto, Padova, , Italy
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
